Home›Stock Screener›Accretion Pharmaceuticals

Accretion Pharmaceuticals Share Price Today | Stock Price & Accretion Pharmaceuticals Share Screener

ACCPL Pharmaceuticals

Track the current Accretion Pharmaceuticals share price and stock price live with TickJournal's free stock screener. Check Accretion Pharmaceuticals yearly highs lows for the annual price range and momentum. Use the Accretion Pharmaceuticals stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Accretion Pharmaceuticals opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Accretion Pharmaceuticals Market Cap ₹237.88 Cr.
ACCPL P/E Ratio (TTM) -
Accretion Pharmaceuticals P/B Ratio 4.29
EPS (TTM) ₹9.03
Dividend Yield -
Debt to Equity 0.38
ACCPL 52 Week High -
Accretion Pharmaceuticals 52 Week Low -
Operating Margin -
Profit Margin -
ACCPL Revenue (TTM) -
EBITDA -
Net Income -
Total Assets ₹77.00
Total Equity ₹55.00

Accretion Pharmaceuticals Share Price Chart

Track the current stock price of Accretion Pharmaceuticals with an interactive chart. Analyse ACCPL share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Accretion Pharmaceuticals stock quote in one place.

Accretion Pharmaceuticals Company Profile - Fundamental Screener

Screen Accretion Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ACCPL shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE0T8T01010.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE0T8T01010

Accretion Pharmaceuticals Balance Sheet Screener

Screen ACCPL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹77, up from ₹40 in 2025.

Latest statistics put total assets at ₹77 and shareholder funds at ₹55, with a leverage ratio of 0.38.

Item 2026 2025 2024

Assets

Total Assets 77 40 27
Current Assets 60 33 22
Fixed Assets 13 6 5

Liabilities

Total Liabilities 0 0 0
Current Liabilities 1 1 7
Non-Current Liabilities 0 0 0

Shareholders' Equity

Total Equity 55 15 6
Share Capital 11 8 4
Reserves & Surplus 44 7 2

Accretion Pharmaceuticals Income Statement Screener - Profit & Revenue Analysis

Screen Accretion Pharmaceuticals income statement and profit fundamentals. Analyze ACCPL quarterly results. Accretion Pharmaceuticals reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹0 and net profit was ₹0.

In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹90 and net profit of ₹10.

Item None-None 2026-March 2025-March 2024-March

Revenue and Expenses

Revenue 0 90 58 13
Expenses 0 75 46 11

Operating Costs and Margins

EBITDA 0 15 12 3
Operating Profit % 0.00% 17.00% 21.00% 19.00%
Depreciation 0 1 1 0
Interest 0 1 1 0

Profit and Earnings

Profit Before Tax 0 13 10 2
Tax 0 3 3 1
Net Profit 0 10 7 2
EPS 0.00 9.03 8.48 1.96

Accretion Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals

Screen ACCPL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities used ₹15, and net cash flow was an inflow of ₹4.

Over the same period, investing activities used ₹9 and financing activities provided ₹27.

Item 2026-March 2025-March 2024-March

Cash from Operations and Investing

Operating Activities -15 -1 -12
Investing Activities -9 -2 -6

Financing and Net Cash

Financing Activities 27 2 17
Net Cash Flow 4 0 0

Accretion Pharmaceuticals Shareholding Pattern Screener

See Accretion Pharmaceuticals shareholding pattern with promoter, FII, and DII holdings. Check Accretion Pharmaceuticals promoter holding and ownership changes for ACCPL on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Jun, promoters held 73.52%, foreign institutions 0.00%, domestic institutions 2.76% and the public 20.22%, spread across 776 shareholders.

The shareholder count was 776 in 2026-Jun, compared with 1,182 in 2026-Mar.

Item 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-May 2025-Jan 2024-Sept

Promoter Holding

Promoter Holding 73.52% 73.52% 73.52% 73.52% 73.50% 73.50% 100.00% 100.00%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 2.76% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 20.22% 22.92% 22.01% 22.85% 21.46% 19.44% 0.00% 0.00%
Other Holding 3.50% 3.56% 4.47% 3.63% 5.04% 7.06% 0.00% 0.00%
Shareholder Count 776 1,182 1,179 1,498 1,628 8 8 8

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Accretion Pharmaceuticals. Accretion Pharmaceuticals dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Accretion Pharmaceuticals.

Accretion Pharmaceuticals Stock Index Membership - Nifty & Sensex

See which indices include Accretion Pharmaceuticals stock. Check ACCPL index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Accretion Pharmaceuticals is not part of any tracked indices.
Only major market indices are tracked in our system.

Accretion Pharmaceuticals Market Events Screener - Corporate Actions

Get Accretion Pharmaceuticals corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Accretion Pharmaceuticals stock events that may affect ACCPL share price, along with derivatives, futures and options activity and sector gainers.

3 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated May 8, 2026, with a record date of May 8, 2026.

It is followed by Quarterly Result Announcement dated November 14, 2025 and Quarterly Result Announcement dated June 11, 2025.

Announcement Date Record Date Event Type Information Price Impact
2026-05-08 2026-05-08 Quarterly Result Announcement NA 3.54%
2025-11-14 2025-11-14 Quarterly Result Announcement NA 16.56%
2025-06-11 2025-06-11 Quarterly Result Announcement NA 5.68%

Accretion Pharmaceuticals Competitors Screener - Peer Stocks Comparison

Screen ACCPL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 435,863 36.83 61,674 12.69% 11,565 38.95
Divis Laboratories 246,660 86.00 11,067 13.95% 2,568 53.27
Torrent Pharmaceuticals 182,577 86.72 13,886 20.34% 2,138 42.82
Zydus Life Science 115,910 25.96 27,658 17.64% 5,026 51.33
Cipla 108,738 33.29 29,045 2.24% 3,870 35.23
Laurus Labs 106,982 98.39 6,868 22.01% 890 58.13
Mankind Pharma 103,418 50.84 14,636 14.85% 1,938 59.40
Dr Reddys Laboratories 102,916 32.77 35,059 3.90% 4,158 62.37
Aurobindo Pharma 96,203 26.41 34,145 5.56% 3,503 49.32
Lupin 92,839 16.97 29,039 26.75% 5,356 31.32

Accretion Pharmaceuticals Company Announcements - News & Reports Screener

Screen ACCPL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

No company announcements available.

Frequently Asked Questions

How is the company valued right now?

The P/B ratio is 4.29. Market capitalisation stands at ₹237.88 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Key statistics were last updated on October 6, 2026. This page covers 3 balance sheet periods, 4 income statement periods, 3 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.